Home » Newsletters » BioWorld Science

BioWorld Science

July 28, 2020

View Archived Issues

Studying labor identifies new pain mechanism

Macromolecular key to reversing multidrug resistance

New rabbit model of atherothrombotic stenosis developed

h-RabMab1 shows promising activity in murine model of PDAC

FRSW-107 demonstrates extended half-life in patients with hemophilia A

New Nav1.7 sodium channel blockers described by Harvard College, Children's Medical Center

Kineta Chronic Pain identifies NACHR alpha-9/alpha-10 antagonists

Cyclic GMP-AMP synthase inhibitors patented by BellBrook Labs

INSERM presents preclinical data for single-domain antibody PS-003

Praxis Biotech discloses new FAPalpha inhibitors

Suzhou Ark Biopharmaceutical presents new hepatitis B virus HBsAg secretion inhibitors

Enrollment ongoing in phase I study of CodaVax-RSV vaccine

Positive topline phase II data announced for AR-1105

NGM Bio initiates phase II CATALINA study of NGM-621

PDS Biotech reports preclinical data for PDS-0203

FDA clears IND for phase I study of Carisma's CAR-M therapy CT-0508

Astellas conducts phase I/II study of ASP-0598 for chronic tympanic membrane perforation

Phase III DAPA-CKD trial of Farxiga meets all primary and secondary endpoints

New genetic variants in RUNX1 gene found in familial platelet disorder with predisposition to AML

Can-Fite submits IND application for phase II study of piclidenoson for COVID-19

Pfizer and BioNTech advance BNT-162b2 into pivotal study for COVID-19

HS-201 studied in phase I for imaging of solid tumors

Adenosine A2A receptor PET radiotracer [18F]FLUDA characterized in vitro and in vivo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...